This inventor holds 1 USPTO granted patent, plus 1 CIPO patent and 1 EPO patent. Top assignee: Japan Immunoresearch Laboratories Co., Ltd.. Active years: 2007.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2007
Title: Manabu Niimi: Innovator in Lipid Metabolism
Introduction
Manabu Niimi is a notable inventor based in Gunma, Japan. He has made significant contributions to the field of lipid metabolism through his innovative research and patenting efforts. His work focuses on high-density lipoprotein-reactive peptides, which have potential applications in treating various diseases.
Latest Patents
Niimi holds a patent for "High density lipoprotein-reactive peptides." This patent describes a high-density lipoprotein-reactive peptide or a foam cell-reactive peptide that can specifically bind to high-density lipoprotein cholesterol or withdraw cholesterol from foam cells. The peptides are characterized by novel amino acid sequences and are useful as drugs for diseases caused by arteriosclerosis, lipid metabolic errors, and peripheral cholesterosis.
Career Highlights
Throughout his career, Manabu Niimi has been associated with Japan Immunoresearch Laboratories Co., Ltd. His work has been instrumental in advancing the understanding of lipid metabolism and its implications for health.
Collaborations
Niimi has collaborated with notable colleagues, including Kazushi Kanatani and Masakazu Adachi, to further his research and development efforts in the field.
Conclusion
Manabu Niimi's contributions to the field of lipid metabolism through his innovative patents highlight his role as a significant inventor. His work has the potential to impact the treatment of various diseases related to cholesterol and lipid metabolism.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile